KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Inventory Average (2016 - 2025)

Neogenomics' Inventory Average history spans 15 years, with the latest figure at $28.5 million for Q4 2025.

  • For Q4 2025, Inventory Average rose 11.37% year-over-year to $28.5 million; the TTM value through Dec 2025 reached $28.5 million, up 11.37%, while the annual FY2025 figure was $27.7 million, 8.66% up from the prior year.
  • Inventory Average reached $28.5 million in Q4 2025 per NEO's latest filing, down from $31.3 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $32.0 million in Q2 2025 to a low of $21.4 million in Q2 2021.
  • Average Inventory Average over 5 years is $24.8 million, with a median of $24.1 million recorded in 2022.
  • Peak YoY movement for Inventory Average: decreased 11.83% in 2024, then soared 46.88% in 2025.
  • A 5-year view of Inventory Average shows it stood at $22.6 million in 2021, then increased by 6.29% to $24.0 million in 2022, then rose by 0.28% to $24.1 million in 2023, then grew by 6.21% to $25.6 million in 2024, then grew by 11.37% to $28.5 million in 2025.
  • Per Business Quant, the three most recent readings for NEO's Inventory Average are $28.5 million (Q4 2025), $31.3 million (Q3 2025), and $32.0 million (Q2 2025).